BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3100882)

  • 1. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
    Waldenström JG
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of anti-histone activity in sera of patients with monoclonal gammopathies.
    Shoenfeld Y; el-Roeiy A; Ben-Yehuda O; Pick AI
    Clin Immunol Immunopathol; 1987 Feb; 42(2):250-8. PubMed ID: 3100119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.
    Mellstedt H; Holm G; Björkholm M
    Adv Cancer Res; 1984; 41():257-89. PubMed ID: 6428176
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives in cancer Research. Specific activities of immunoglobulins produced in monoclonal gammapathy--maladies of derepression.
    Waldenström JG
    Eur J Cancer (1965); 1976 Jun; 12(6):413-8. PubMed ID: 821732
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias.
    Merlini G; Farhangi M; Osserman EF
    Semin Oncol; 1986 Sep; 13(3):350-65. PubMed ID: 3094150
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenström's macroglobulinemia.
    Hansotia P; Gani K; Friedenberg W
    Neurology; 1983 Nov; 33(11):1411-5. PubMed ID: 6415510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M protein idiotype in patients with monoclonal gammopathies.
    Sugai S; Shimizu S; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1749-56. PubMed ID: 3105208
    [No Abstract]   [Full Text] [Related]  

  • 10. "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.
    Kyle RA
    Mayo Clin Proc; 1993 Jan; 68(1):26-36. PubMed ID: 8417251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1195-205. PubMed ID: 3492847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polyclonal immunoglobulins in serum in obligatory and facultative monoclonal gammopathies].
    Hrncírová L; Máchová L
    Vnitr Lek; 1982 Feb; 28(2):116-21. PubMed ID: 6801853
    [No Abstract]   [Full Text] [Related]  

  • 13. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic propensity to benignity in monoclonal-gammopathy.
    Youinou P
    Acta Haematol; 1979; 62(3):173-5. PubMed ID: 118617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [M-components in blood donors in Antwerp. Studies on the incidence and course in 24 donors].
    van Camp B; Cole J; Peetermans ME
    Acta Clin Belg; 1976; 31(4):203-11. PubMed ID: 827176
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts on monoclonal gammopathies.
    Kyle RA
    Aust N Z J Med; 1992 Jun; 22(3):291-302. PubMed ID: 1497556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of monoclonal gammopathies].
    Hurez D
    Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience.
    Frustaci AM; Nichelatti M; Deodato M; Zamprogna G; Minga P; Pioltelli ML; Cairoli R; Tedeschi A
    Hematol Oncol; 2020 Feb; 38(1):111-113. PubMed ID: 31852014
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.
    Karlsson J; Andréasson B; Kondori N; Erman E; Riesbeck K; Hogevik H; Wennerås C
    Clin Vaccine Immunol; 2011 Jun; 18(6):969-77. PubMed ID: 21508164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.